Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: A case-control study

Terence Burns, Gustavo J. Rodriguez, S. Patel, H. M. Hussein, A. L. Georgiadis, K. Lakshminarayan, A. I. Qureshi

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

BACKGROUND AND PURPOSE: Since the introduction of recombinant tissue plasminogen activator (rtPA) into clinical practice in the mid 1990s, no adjunctive treatment has further improved clinical outcomes in patients with ischemic stroke. The safety, feasibility, and efficacy of combining intravenous (IV) rtPA with endovascular interventions has been described; however, no direct comparative study has yet established whether endovascular interventions after IV rtPA are superior to IV rtPA alone. A retrospective case-control study was designed to address this issue. MATERIALS AND METHODS: Between 2003 and 2006, 33 consecutive patients with acute ischemic stroke and National Institutes of Health Stroke Scale (NIHSS) scores ≥10 were treated with IV rtPA in combination with endovascular interventions (IV plus intervention) at a tertiary care facility. Outcomes were compared with a control cohort of 30 consecutive patients treated with IV rtPA (IV only) at a comparable facility where endovascular interventions were not available. RESULTS: Baseline parameters were similar between the 2 groups. We found that the IV-plus-intervention group experienced significantly lower mortality at 90 days (12.1% versus 40.0%, P = .019) with a significantly greater improvement in NIHSS scores by the time of discharge or follow-up (P = .025). In the IV-plus-intervention group, patients with admission NIHSS scores between 10 and 15 and patients ≤80 years of age showed the greatest improvement, with a significant change of the NIHSS scores from admission (P = .00015 and P = .013, respectively). CONCLUSIONS: In this small case-control study of patients with acute ischemic stroke and admission NIHSS scores ≥10, there was a suggestion of incremental clinical benefit among patients receiving endovascular interventions following standard administration of IV rtPA.

Original languageEnglish (US)
Pages (from-to)1918-1924
Number of pages7
JournalAmerican Journal of Neuroradiology
Volume29
Issue number10
DOIs
StatePublished - Nov 1 2008
Externally publishedYes

Fingerprint

Tissue Plasminogen Activator
Case-Control Studies
Stroke
National Institutes of Health (U.S.)
Survival
Patient Admission
Tertiary Healthcare
Intravenous Administration
Safety
Mortality

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Clinical Neurology

Cite this

Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke : A case-control study. / Burns, Terence; Rodriguez, Gustavo J.; Patel, S.; Hussein, H. M.; Georgiadis, A. L.; Lakshminarayan, K.; Qureshi, A. I.

In: American Journal of Neuroradiology, Vol. 29, No. 10, 01.11.2008, p. 1918-1924.

Research output: Contribution to journalArticle

Burns, Terence ; Rodriguez, Gustavo J. ; Patel, S. ; Hussein, H. M. ; Georgiadis, A. L. ; Lakshminarayan, K. ; Qureshi, A. I. / Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke : A case-control study. In: American Journal of Neuroradiology. 2008 ; Vol. 29, No. 10. pp. 1918-1924.
@article{fc303aec67d7481c8374986374328c4b,
title = "Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke: A case-control study",
abstract = "BACKGROUND AND PURPOSE: Since the introduction of recombinant tissue plasminogen activator (rtPA) into clinical practice in the mid 1990s, no adjunctive treatment has further improved clinical outcomes in patients with ischemic stroke. The safety, feasibility, and efficacy of combining intravenous (IV) rtPA with endovascular interventions has been described; however, no direct comparative study has yet established whether endovascular interventions after IV rtPA are superior to IV rtPA alone. A retrospective case-control study was designed to address this issue. MATERIALS AND METHODS: Between 2003 and 2006, 33 consecutive patients with acute ischemic stroke and National Institutes of Health Stroke Scale (NIHSS) scores ≥10 were treated with IV rtPA in combination with endovascular interventions (IV plus intervention) at a tertiary care facility. Outcomes were compared with a control cohort of 30 consecutive patients treated with IV rtPA (IV only) at a comparable facility where endovascular interventions were not available. RESULTS: Baseline parameters were similar between the 2 groups. We found that the IV-plus-intervention group experienced significantly lower mortality at 90 days (12.1{\%} versus 40.0{\%}, P = .019) with a significantly greater improvement in NIHSS scores by the time of discharge or follow-up (P = .025). In the IV-plus-intervention group, patients with admission NIHSS scores between 10 and 15 and patients ≤80 years of age showed the greatest improvement, with a significant change of the NIHSS scores from admission (P = .00015 and P = .013, respectively). CONCLUSIONS: In this small case-control study of patients with acute ischemic stroke and admission NIHSS scores ≥10, there was a suggestion of incremental clinical benefit among patients receiving endovascular interventions following standard administration of IV rtPA.",
author = "Terence Burns and Rodriguez, {Gustavo J.} and S. Patel and Hussein, {H. M.} and Georgiadis, {A. L.} and K. Lakshminarayan and Qureshi, {A. I.}",
year = "2008",
month = "11",
day = "1",
doi = "10.3174/ajnr.A1236",
language = "English (US)",
volume = "29",
pages = "1918--1924",
journal = "American Journal of Neuroradiology",
issn = "0195-6108",
publisher = "American Society of Neuroradiology",
number = "10",

}

TY - JOUR

T1 - Endovascular interventions following intravenous thrombolysis may improve survival and recovery in patients with acute ischemic stroke

T2 - A case-control study

AU - Burns, Terence

AU - Rodriguez, Gustavo J.

AU - Patel, S.

AU - Hussein, H. M.

AU - Georgiadis, A. L.

AU - Lakshminarayan, K.

AU - Qureshi, A. I.

PY - 2008/11/1

Y1 - 2008/11/1

N2 - BACKGROUND AND PURPOSE: Since the introduction of recombinant tissue plasminogen activator (rtPA) into clinical practice in the mid 1990s, no adjunctive treatment has further improved clinical outcomes in patients with ischemic stroke. The safety, feasibility, and efficacy of combining intravenous (IV) rtPA with endovascular interventions has been described; however, no direct comparative study has yet established whether endovascular interventions after IV rtPA are superior to IV rtPA alone. A retrospective case-control study was designed to address this issue. MATERIALS AND METHODS: Between 2003 and 2006, 33 consecutive patients with acute ischemic stroke and National Institutes of Health Stroke Scale (NIHSS) scores ≥10 were treated with IV rtPA in combination with endovascular interventions (IV plus intervention) at a tertiary care facility. Outcomes were compared with a control cohort of 30 consecutive patients treated with IV rtPA (IV only) at a comparable facility where endovascular interventions were not available. RESULTS: Baseline parameters were similar between the 2 groups. We found that the IV-plus-intervention group experienced significantly lower mortality at 90 days (12.1% versus 40.0%, P = .019) with a significantly greater improvement in NIHSS scores by the time of discharge or follow-up (P = .025). In the IV-plus-intervention group, patients with admission NIHSS scores between 10 and 15 and patients ≤80 years of age showed the greatest improvement, with a significant change of the NIHSS scores from admission (P = .00015 and P = .013, respectively). CONCLUSIONS: In this small case-control study of patients with acute ischemic stroke and admission NIHSS scores ≥10, there was a suggestion of incremental clinical benefit among patients receiving endovascular interventions following standard administration of IV rtPA.

AB - BACKGROUND AND PURPOSE: Since the introduction of recombinant tissue plasminogen activator (rtPA) into clinical practice in the mid 1990s, no adjunctive treatment has further improved clinical outcomes in patients with ischemic stroke. The safety, feasibility, and efficacy of combining intravenous (IV) rtPA with endovascular interventions has been described; however, no direct comparative study has yet established whether endovascular interventions after IV rtPA are superior to IV rtPA alone. A retrospective case-control study was designed to address this issue. MATERIALS AND METHODS: Between 2003 and 2006, 33 consecutive patients with acute ischemic stroke and National Institutes of Health Stroke Scale (NIHSS) scores ≥10 were treated with IV rtPA in combination with endovascular interventions (IV plus intervention) at a tertiary care facility. Outcomes were compared with a control cohort of 30 consecutive patients treated with IV rtPA (IV only) at a comparable facility where endovascular interventions were not available. RESULTS: Baseline parameters were similar between the 2 groups. We found that the IV-plus-intervention group experienced significantly lower mortality at 90 days (12.1% versus 40.0%, P = .019) with a significantly greater improvement in NIHSS scores by the time of discharge or follow-up (P = .025). In the IV-plus-intervention group, patients with admission NIHSS scores between 10 and 15 and patients ≤80 years of age showed the greatest improvement, with a significant change of the NIHSS scores from admission (P = .00015 and P = .013, respectively). CONCLUSIONS: In this small case-control study of patients with acute ischemic stroke and admission NIHSS scores ≥10, there was a suggestion of incremental clinical benefit among patients receiving endovascular interventions following standard administration of IV rtPA.

UR - http://www.scopus.com/inward/record.url?scp=56849119889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56849119889&partnerID=8YFLogxK

U2 - 10.3174/ajnr.A1236

DO - 10.3174/ajnr.A1236

M3 - Article

C2 - 18784214

AN - SCOPUS:56849119889

VL - 29

SP - 1918

EP - 1924

JO - American Journal of Neuroradiology

JF - American Journal of Neuroradiology

SN - 0195-6108

IS - 10

ER -